Download PDF
J Reconstr Microsurg
DOI: 10.1055/a-2302-6992
Original Article

New-Onset Atrial Fibrillation Is a Red Flag to Microvascular Free Tissue Transfer Failure in Head and Neck Cancer Patients

Chia-Hsuan Tsai
1   Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Keelung & Chang Gung University College of Medicine, Keelung, Taiwan
,
Yu-Jen Chen
2   Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkuo & Chang Gung University College of Medicine, Taoyuan, Taiwan
,
Yu-Chih Lin
3   Research Services Center for Health Information, Chang Gung University, Taoyuan City, Taiwan
,
Yao-Chang Liu
1   Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Keelung & Chang Gung University College of Medicine, Keelung, Taiwan
,
Huang-Kai Kao
2   Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkuo & Chang Gung University College of Medicine, Taoyuan, Taiwan
,
Shih-Hsuan Mao
2   Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkuo & Chang Gung University College of Medicine, Taoyuan, Taiwan
› Author Affiliations Funding This study was funded by the Ministry of Science and Technology, Taiwan (MOST109-2314-B-182-022 and MOST110-2314-B-182A-106-MY2).
› Further Information
   Permissions and Reprints

Abstract

Background Postoperative new-onset atrial fibrillation (AF) has been shown to be associated with increased surgical morbidity and mortality following cancer ablation surgery. However, evidence of new-onset AF's impact on surgical outcomes in head and neck cancer patients undergoing tumor ablation and microvascular free tissue transfer remains scarce. This study aims to evaluate the association between AF and surgical outcomes in these patients.

Methods We enrolled head and neck cancer patients who underwent tumor ablation reconstructed with microvascular free tissue transfer from the National Health Insurance Research Database (NHIRD). Patients were grouped into the following: (1) without AF, (2) new-onset AF, and (3) preexisting AF. The groups were matched by propensity score based on age, gender, cancer stage, and comorbidities. The primary outcome was postoperative complications, whereas all-cause mortality was the secondary outcome.

Results In total, 26,817 patients were included in this study. After matching, we identified 2,176 (79.24%) patients without AF, 285 (10.37%) with preexisting AF, and 285 (10.37%) with new-onset AF. Our results demonstrated that the free flap failure rate was twofold escalated in patients with new-onset AF (9.8%) compared to those without AF (5.4%) or preexisting AF (5.3%; p = 0.01). However, we did not identify significant differences among other postoperative complications across groups. Additionally, we found that the risk of all-cause mortality was significantly elevated in patients with preexisting AF (p < 0.001) compared to those without AF or new-onset AF.

Conclusion Our study demonstrated that new-onset AF is associated with an increased risk of flap failure and could serve as a predictor. On the other hand, all-cause mortality in patients with preexisting AF was significantly elevated. Close postoperative monitoring in patients with new-onset and preexisting AF is crucial to identify any potential adverse effects.

Keywords

new-onset atrial fibrillation - preexisting atrial fibrillation - head and neck cancer - microvascular free tissue transfer - flap failure

Supplementary Material



Publication History

Received: 21 November 2023

Accepted: 27 March 2024

Accepted Manuscript online:
09 April 2024

Article published online:
13 May 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16 (07) 417-436
    CrossrefPubMedGoogle Scholar
  • 2 Danelich IM, Lose JM, Wright SS. et al. Practical management of postoperative atrial fibrillation after noncardiac surgery. J Am Coll Surg 2014; 219 (04) 831-841
    CrossrefPubMedGoogle Scholar
  • 3 Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost 2015; 13 (Suppl. 01) S304-S312
    CrossrefPubMedGoogle Scholar
  • 4 Gialdini G, Nearing K, Bhave PD. et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312 (06) 616-622
    CrossrefPubMedGoogle Scholar
  • 5 Roselli EE, Murthy SC, Rice TW. et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 2005; 130 (02) 438-444
    CrossrefPubMedGoogle Scholar
  • 6 Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L. Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg 2012; 7: 4
    CrossrefPubMedGoogle Scholar
  • 7 Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003; 126 (04) 1162-1167
    CrossrefPubMedGoogle Scholar
  • 8 Chin JH, Moon YJ, Jo JY. et al. Association between postoperatively developed atrial fibrillation and long-term mortality after esophagectomy in esophageal cancer patients: an observational study. PLoS One 2016; 11 (05) e0154931
    CrossrefPubMedGoogle Scholar
  • 9 Mc Cormack O, Zaborowski A, King S. et al. New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes. Ann Surg 2014; 260 (05) 772-778 , discussion 778
    CrossrefPubMedGoogle Scholar
  • 10 Siu CW, Tung HM, Chu KW, Jim MH, Lau CP, Tse HF. Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Pacing Clin Electrophysiol 2005; 28 (Suppl. 01) S120-S123
    PubMedGoogle Scholar
  • 11 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
    CrossrefPubMedGoogle Scholar
  • 12 International Agency for Research on Cancer. GLOBOCAN 2020 database, 2020. Accessed May 22, 2023 at: https://www-dep.iarc.fr/
    PubMedGoogle Scholar
  • 13 Liao CT, Ng SH, Chang JT. et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 2007; 43 (06) 570-579
    CrossrefPubMedGoogle Scholar
  • 14 Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet 2021; 398 (10318): 2289-2299
    CrossrefPubMedGoogle Scholar
  • 15 Smith RB, Sniezek JC, Weed DT, Wax MK. Microvascular Surgery Subcommittee of American Academy of Otolaryngology–Head and Neck Surgery. Utilization of free tissue transfer in head and neck surgery. Otolaryngol Head Neck Surg 2007; 137 (02) 182-191
    CrossrefPubMedGoogle Scholar
  • 16 Krijgh DD, Mureau MA. Reconstructive options in patients with late complications after surgery and radiotherapy for head and neck cancer: remember the deltopectoral flap. Ann Plast Surg 2013; 71 (02) 181-185
    CrossrefPubMedGoogle Scholar
  • 17 Ho AS, Kim S, Tighiouart M. et al. Quantitative survival impact of composite treatment delays in head and neck cancer. Cancer 2018; 124 (15) 3154-3162
    CrossrefPubMedGoogle Scholar
  • 18 Weyh AM, Esmail K, Yekikian M. et al. Head and neck surgery is a risk factor for atrial fibrillation: incidence and outcomes. Int J Oral Maxillofac Implants 2020; 49 (12) 1535-1541
    CrossrefPubMedGoogle Scholar
  • 19 Sakisaka M, Kurita M, Okazaki M, Kagaya Y, Takushima A, Harii K. Drug-induced atrial fibrillation complicates the results of flap surgery in a rat model. Ann Plast Surg 2016; 76 (02) 244-248
    CrossrefPubMedGoogle Scholar
  • 20 Lee HF, Chan YH, Chang SH. et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation. J Am Heart Assoc 2019; 8 (05) e011112
    CrossrefPubMedGoogle Scholar
  • 21 Mahmoudi E, Lu Y, Chang SC. et al. Associations of surgeon and hospital volumes with outcome for free tissue transfer by using the National Taiwan Population Health Care Data from 2001 to 2012. Plast Reconstr Surg 2017; 140 (03) 455e-465e
    CrossrefPubMedGoogle Scholar
  • 22 Chang CH, Fan PC, Lin YS. et al. Atrial fibrillation and associated outcomes in patients with peritoneal dialysis and hemodialysis: a 14-year nationwide population-based study. J Nephrol 2021; 34 (01) 53-62
    CrossrefPubMedGoogle Scholar
  • 23 Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation: a nationwide descriptive study in Taiwan. Clin Ther 2008; 30 (09) 1726-1736
    CrossrefPubMedGoogle Scholar
  • 24 Chang CH, Lee YC, Tsai CT. et al. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis 2014; 232 (01) 224-230
    CrossrefPubMedGoogle Scholar
  • 25 Chen KT, Mardini S, Chuang DC. et al. Timing of presentation of the first signs of vascular compromise dictates the salvage outcome of free flap transfers. Plast Reconstr Surg 2007; 120 (01) 187-195
    CrossrefPubMedGoogle Scholar
  • 26 Gusenoff JA, Vega SJ, Jiang S. et al. Free tissue transfer: comparison of outcomes between university hospitals and community hospitals. Plast Reconstr Surg 2006; 118 (03) 671-675
    CrossrefPubMedGoogle Scholar
  • 27 Slijepcevic AA, Young G, Shinn J. et al. Success and outcomes following a second salvage attempt for free flap compromise in patients undergoing head and neck reconstruction. JAMA Otolaryngol Head Neck Surg 2022; 148 (06) 555-560
    CrossrefPubMedGoogle Scholar
  • 28 Hagau N, Longrois D. Anesthesia for free vascularized tissue transfer. Microsurgery 2009; 29 (02) 161-167
    CrossrefPubMedGoogle Scholar
  • 29 Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L. Canadian Critical Care Trials Group. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care 2012; 27 (03) 326.e1-326.e8
    CrossrefPubMedGoogle Scholar
  • 30 Yazar S, Wei FC, Chen HC. et al. Selection of recipient vessels in double free-flap reconstruction of composite head and neck defects. Plast Reconstr Surg 2005; 115 (06) 1553-1561
    CrossrefPubMedGoogle Scholar
  • 31 Courret T, Tourdias T, Papaxanthos J. et al. Etiologic and prognostic value of external carotid artery thrombus detection during endovascular therapy for anterior circulation proximal occlusions. Eur J Neurol 2023; 30 (02) 380-388
    CrossrefPubMedGoogle Scholar
  • 32 Deniz C, Altunan B, Aykaç Ö, Özdemir AÖ. Coexistence of external carotid artery embolus and internal carotid artery occlusion in acute ischemic stroke: an indicator of cardioembolic etiology?. J Stroke Cerebrovasc Dis 2022; 31 (09) 106630
    CrossrefPubMedGoogle Scholar
  • 33 Barton BM, Riley CA, Fitzpatrick JC, Hasney CP, Moore BA, McCoul ED. Postoperative anticoagulation after free flap reconstruction for head and neck cancer: a systematic review. Laryngoscope 2018; 128 (02) 412-421
    CrossrefPubMedGoogle Scholar
  • 34 Bagheri R, Yousefi Y, Rezai R, Azemonfar V, Keshtan FG. Atrial fibrillation after lung surgery: incidence, underlying factors, and predictors. Kardiochir Torakochirurgia Pol 2019; 16 (02) 53-56
    PubMedGoogle Scholar
  • 35 Alsop BR, Sharma P. Esophageal cancer. Gastroenterol Clin North Am 2016; 45 (03) 399-412
    CrossrefPubMedGoogle Scholar
  • 36 Prasada S, Desai MY, Saad M. et al. Preoperative atrial fibrillation and cardiovascular outcomes after noncardiac surgery. J Am Coll Cardiol 2022; 79 (25) 2471-2485
    CrossrefPubMedGoogle Scholar
  • 37 Ozcan C, Jahangir A, Friedman PA. et al. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction. Am J Cardiol 2003; 92 (01) 33-37
    CrossrefPubMedGoogle Scholar
  • 38 Anderson E, Dyke C, Levy JH. Anticoagulation strategies for the management of postoperative atrial fibrillation. Clin Lab Med 2014; 34 (03) 537-561
    CrossrefPubMedGoogle Scholar